Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $73.44 USD
Change Today +1.23 / 1.70%
Volume 326.2K
CLVS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven L. Hoerter

Senior Vice President of Commercial, Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

43$1,329,380
As of Fiscal Year 2013

Background*

Mr. Steven L. Hoerter has been Senior Vice President of Commercial Operations at Clovis Oncology, Inc. since August 2011. From 2010 to 2011, Mr. Hoerter served as General Manager and Management Center Head at F. Hoffmann-La Roche Ltd. for the Sub-Saharan Africa and Indian Ocean Region, based in Johannesburg, South Africa. From 2005 to 2010, Mr. Hoerter held a variety of positions at Genentech, Inc., including serving on the senior leadership team for Genentech's BioOncology ...

Read Full Background

Corporate Headquarters*

2525 28th Street
Boulder, Colorado 80301

United States

Phone: 303-625-5000
Fax: 303-245-0360

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
Purdue University
BA
Bucknell University
MBA
Universiteit van Tilburg

Other Affiliations*

Annual Compensation*

Salary$322,917
Bonus$178,475
Total Annual Compensation$501,392

Stock Options*

All Other Compensation$13,242
Exercised Options10,000
Exercised Options Value$739,100
Exercisable Options76,537
Exercisable Options Value$3,409,297
Unexercisable Options129,669
Unexercisable Options Value$5,275,748
Total Value of Options$9,424,145
Total Number of Options216,206

Total Compensation*

Total Annual Cash Compensation$514,634
Total Short Term Compensation$501,392
Other Long Term Compensation$13,242
Total Calculated Compensation$1,329,380
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $73.44 USD +1.23

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.